Paragon Genomics is advancing next-generation sequencing (NGS) and precision medicine with high-quality genomic sequencing. NGS is used in far reaching applications from precision oncology, infectious disease testing, single cell analysis to molecular breeding. To fuel work in these areas, Paragon is creating and commercializing technologies and products that efficiently and rapidly produce unique and customized NGS assays. These assays are made using Paragon’s proprietary primer design and library preparation technologies. For example, Paragon developed their COVID-19 NGS assay within a month and has been widely adopted by researchers and clinicians. The assay uses Paragon’s CleanPlex technology to amplify the entire viral genome.

<p>Paragon Genomics is advancing next-generation sequencing (NGS) and precision medicine with high-quality genomic sequencing. NGS is used in far reaching applications from precision oncology, infectious disease testing, single cell analysis to molecular breeding. To fuel work in these areas, Paragon is creating and commercializing technologies and products that efficiently and rapidly produce unique and customized NGS assays. These assays are made using Paragon’s proprietary primer design and library preparation technologies. For example, Paragon developed their COVID-19 NGS assay within a month and has been widely adopted by researchers and clinicians. The assay uses Paragon’s CleanPlex technology to amplify the entire viral genome.</p>


Paragon Genomics

Founded: 2015
Location: Hayward, CA
Employee range: 1-50
Funding: &lt;10M

Short description:

Drug notes:

Long description:

Jobs: